文献速递关节外科

全髋关节置换术中关节腔内联合给予万古霉素与ε-氨基己酸的临床研究:安全性与疗效

Safety and efficacy of combined intra-articular administration of vancomycin and ε-aminocaproic acid in total hip arthroplasty : a clinical study.
PubMed 文献 · Bone Joint J · 2025-02-01

研究纳入120例单侧初次全髋关节置换术患者,分为关节腔内万古霉素联合ε-氨基己酸组(VE组)、单用万古霉素组(V组)和单用ε-氨基己酸组(E组)。结果显示E组与VE组失血量相当且少于V组,VE组各时间点关节腔内万古霉素水平更高而各组血清水平相似,未观察到急性肾损伤、耳毒性、过敏反应,假体周围感染率无差异。结论认为在万古霉素基础上加用关节腔内ε-氨基己酸不影响万古霉素关节腔内水平,并维持了ε-氨基己酸的抗纤溶作用。

要点

  • E组与VE组失血量相当,且均少于V组。
  • VE组各时间点关节腔内万古霉素水平更高,各组血清万古霉素水平相似。
  • 未观察到急性肾损伤、耳毒性、过敏反应,假体周围感染率无差异。

核心结论

  • 在万古霉素基础上加用关节腔内ε-氨基己酸不影响万古霉素的关节腔内水平,并维持了ε-氨基己酸的抗纤溶作用。

研究设计与样本

  • 共120例接受单侧初次全髋关节置换术的患者被分为三组:VE组关节腔内给予万古霉素和ε-氨基己酸,V组仅关节腔内给予万古霉素,E组仅关节腔内给予ε-氨基己酸。
  • 术后采集血液和关节液,采用色谱法测定万古霉素水平,并监测失血量和肾功能。

主要发现

  • E组与VE组失血量相当,且均少于V组。
  • VE组各时间点关节腔内万古霉素水平均更高,而各组血清万古霉素水平相似。
  • 未观察到急性肾损伤、耳毒性或过敏反应,假体周围感染率也无差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To evaluate the concurrent use of vancomycin and ε-aminocaproic acid (EACA) in primary total hip arthroplasty (THA). METHODS: In total, 120 patients undergoing unilateral primary THA were divided into three groups: Group VE received intra-articular vancomycin and EACA; Group V received only intra-articular vancomycin; and Group E received only intra-articular EACA. Blood and joint fluids were sampled postoperatively to measure the vancomycin levels using chromatography. Blood loss and kidney function were monitored. RESULTS: Groups E and VE had equivalent blood loss, which was less than that in Group V. Intra-articular vancomycin levels were higher in Group VE at all intervals, with similar serum levels across the groups. Acute kidney injury, ototoxicity, and allergies were not observed, nor was a difference in rates of periprosthetic joint infection. CONCLUSION: Adding intra-articular EACA to vancomycin did not affect intra-articular vancomycin levels, and maintained EACA's antifibrinolytic effects.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Hu M, Zhang Y, Guo C, et al. Safety and efficacy of combined intra-articular administration of vancomycin and ε-aminocaproic acid in total hip arthroplasty : a clinical study. Bone Joint J. 2025. PMID: 39889741. doi:10.1302/0301-620X.107B2.BJJ-2024-0232.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。